A Multi-Center Controlled Screening Trial of Safety and Efficacy of Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rasagiline (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
Most Recent Events
- 18 May 2018 Biomarkers information updated
- 29 Mar 2012 Additional lead trial centre identified, actual initiation date changed from Sep 2010 to Dec 2011 and additional location (Canada) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Planned number of patients changed from 60 to 30 as reported by ClinicalTrials.gov.